322 related articles for article (PubMed ID: 16611303)
1. Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype.
Worth A; Thrasher AJ; Gaspar HB
Br J Haematol; 2006 Apr; 133(2):124-40. PubMed ID: 16611303
[TBL] [Abstract][Full Text] [Related]
2. ALPS: an autoimmune human lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
Puck JM; Sneller MC
Semin Immunol; 1997 Feb; 9(1):77-84. PubMed ID: 9106310
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune lymphoproliferative syndrome with somatic Fas mutations.
Holzelova E; Vonarbourg C; Stolzenberg MC; Arkwright PD; Selz F; Prieur AM; Blanche S; Bartunkova J; Vilmer E; Fischer A; Le Deist F; Rieux-Laucat F
N Engl J Med; 2004 Sep; 351(14):1409-18. PubMed ID: 15459302
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune lymphoproliferative syndrome: a cause of chronic splenomegaly, lymphadenopathy, and cytopenias in children-report on diagnosis and management of five patients.
Alvarado CS; Straus SE; Li S; Dale JK; Mann K; Le A; Lauer SJ
Pediatr Blood Cancer; 2004 Aug; 43(2):164-9. PubMed ID: 15236285
[TBL] [Abstract][Full Text] [Related]
5. Identical phenotype in patients with somatic and germline CD95 mutations requires a new diagnostic approach to autoimmune lymphoproliferative syndrome.
Rössler J; Enders A; Lahr G; Heitger A; Winkler K; Fuchs H; Kopp M; Niemeyer C; Ehl S
J Pediatr; 2005 Nov; 147(5):691-4. PubMed ID: 16291365
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune lymphoproliferative syndrome (ALPS) in a patient with a new germline Fas gene mutation.
Del-Rey MJ; Manzanares J; Bosque A; Aguiló JI; Gómez-Rial J; Roldan E; Serrano A; Anel A; Paz-Artal E; Allende LM
Immunobiology; 2007; 212(2):73-83. PubMed ID: 17336828
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways.
Rieux-Laucat F; Le Deist F; Fischer A
Cell Death Differ; 2003 Jan; 10(1):124-33. PubMed ID: 12655301
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune lymphoproliferative syndrome (ALPS) caused by Fas (CD95) mutation mimicking sarcoidosis.
Müllauer L; Emhofer J; Wohlfart S; Pichlhöfer B; Stary S; Ebetsberger G; Mannhalter C; Chott A
Am J Surg Pathol; 2008 Feb; 32(2):329-34. PubMed ID: 18223337
[TBL] [Abstract][Full Text] [Related]
9. Impaired apoptosis of lymphocytes derived from patient with decreased expression of caspase-8 results in Alps-like phenotype.
Grzela T; Krauze A; Grzela K; Lazarczyk M; Niderla J; Brawura-Biskupski-Samaha R; Dziunycz P; Milewski L; Korczak-Kowalska G; Kulus M
Int J Mol Med; 2004 Nov; 14(5):937-42. PubMed ID: 15492869
[TBL] [Abstract][Full Text] [Related]
10. Inherited and acquired death receptor defects in human Autoimmune Lymphoproliferative Syndrome.
Rieux-Laucat F
Curr Dir Autoimmun; 2006; 9():18-36. PubMed ID: 16394653
[TBL] [Abstract][Full Text] [Related]
11. Correction of autoimmune lymphoproliferative syndrome by bone marrow transplantation.
Sleight BJ; Prasad VS; DeLaat C; Steele P; Ballard E; Arceci RJ; Sidman CL
Bone Marrow Transplant; 1998 Aug; 22(4):375-80. PubMed ID: 9722073
[TBL] [Abstract][Full Text] [Related]
12. Advances in autoimmune lymphoproliferative syndromes.
Madkaikar M; Mhatre S; Gupta M; Ghosh K
Eur J Haematol; 2011 Jul; 87(1):1-9. PubMed ID: 21447005
[TBL] [Abstract][Full Text] [Related]
13. [Autoimmune lymphoproliferative syndrome: an inherited or a somatic defect of apoptosis].
Rieux-Laucat F
Med Sci (Paris); 2006; 22(6-7):645-50. PubMed ID: 16828042
[TBL] [Abstract][Full Text] [Related]
14. Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndrome.
Shenoy S; Arnold S; Chatila T
J Pediatr; 2000 May; 136(5):682-7. PubMed ID: 10802504
[TBL] [Abstract][Full Text] [Related]
15. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity.
Drappa J; Vaishnaw AK; Sullivan KE; Chu JL; Elkon KB
N Engl J Med; 1996 Nov; 335(22):1643-9. PubMed ID: 8929361
[TBL] [Abstract][Full Text] [Related]
16. [The autoimmune lymphoproliferative syndrome: a disorder of programmed cell death].
Seegers D; Peña AS; Bouma G
Ned Tijdschr Geneeskd; 2004 Feb; 148(8):371-6. PubMed ID: 15032090
[TBL] [Abstract][Full Text] [Related]
17. HLA B44 is associated with decreased severity of autoimmune lymphoproliferative syndrome in patients with CD95 defects (ALPS type Ia).
Vacek MM; Schäffer AA; Davis J; Fischer RE; Dale JK; Adams S; Straus SE; Puck JM
Clin Immunol; 2006 Jan; 118(1):59-65. PubMed ID: 16257267
[TBL] [Abstract][Full Text] [Related]
18. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency.
Chun HJ; Zheng L; Ahmad M; Wang J; Speirs CK; Siegel RM; Dale JK; Puck J; Davis J; Hall CG; Skoda-Smith S; Atkinson TP; Straus SE; Lenardo MJ
Nature; 2002 Sep; 419(6905):395-9. PubMed ID: 12353035
[TBL] [Abstract][Full Text] [Related]
19. The spectrum of apoptotic defects and clinical manifestations, including systemic lupus erythematosus, in humans with CD95 (Fas/APO-1) mutations.
Vaishnaw AK; Toubi E; Ohsako S; Drappa J; Buys S; Estrada J; Sitarz A; Zemel L; Chu JL; Elkon KB
Arthritis Rheum; 1999 Sep; 42(9):1833-42. PubMed ID: 10513797
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune lymphoproliferative syndrome in a patient with common variable immunodeficiency: dichotomy of apoptosis.
Narra MB; Abdou NI
Ann Allergy Asthma Immunol; 2007 Jun; 98(6):585-8. PubMed ID: 17601274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]